Literature DB >> 1849444

Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model.

H Tanimoto1, K H Lau, S K Nishimoto, J E Wergedal, D J Baylink.   

Abstract

The present study examined the usefulness of the serum alkaline phosphatase (ALP) activity, osteocalcin, and tartrate-resistant acid phosphatase (TrACP) activity as bone turnover markers in a calcium depletion/repletion rat model. Weanling rats were fed calcium-deficient diet for 4 weeks, followed by 2 weeks of dietary calcium repletion. Serum phosphatases and osteocalcin were determined and compared with those of corresponding age-matched, pair-weighted controls. Rats were sacrificed at the end of each phase of the study, and bone phosphatase activities in tibiae and vertebrae were measured. During calcium depletion, rats developed hypocalcemia and lost significant bone calcium, which were reversed with dietary calcium repletion. During depletion when previously published histologic studies indicated a suppressed bone formation and stimulated bone resorption, serum ALP activity and osteocalcin levels were significantly elevated and serum TrACP activity reduced; at the same time, the bone ALP and TrACP activities were increased. Because the serum level of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) which has been shown to stimulate the synthesis of skeletal ALP and of osteocalcin, was also significantly increased during depletion, the increased serum ALP and osteocalcin level could be indirect consequences of the hypocalcemia-mediated elevation in 1,25(OH)2D3 level. These effects were reversed upon calcium repletion, during which previously published histologic studies demonstrated a stimulated bone formation and a suppressed resorption in these rats. In conclusion, although there is increasing evidence for the usefulness of these serum proteins as markers of bone metabolism in humans, a great deal more work is required before we can understand the significance of these assays. Until such is accomplished, these assays should not be assumed to be validated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849444     DOI: 10.1007/bf02555874

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  43 in total

1.  Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions.

Authors:  C Y Li; L T Yam; K W Lam
Journal:  J Histochem Cytochem       Date:  1970-07       Impact factor: 2.479

2.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

3.  Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues.

Authors:  K W Lam; P Lee; C Y Li; L T Yam
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

4.  Age and sex dependency of the biochemical indices of bone remodelling.

Authors:  J J Stĕpán; A Tesarová; T Havránek; J Jodl; J Formánková; V Pacovský
Journal:  Clin Chim Acta       Date:  1985-10-15       Impact factor: 3.786

5.  Specific measurement of DNA in nuclei and nucleic acids using diaminobenzoic acid.

Authors:  P S Thomas; M N Farquhar
Journal:  Anal Biochem       Date:  1978-08-15       Impact factor: 3.365

6.  Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.

Authors:  P J Marie; R Travers
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

7.  Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. Evidence for an intracellular precursor.

Authors:  S K Nishimoto; P A Price
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

8.  Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.

Authors:  J B Lian; D L Carnes; M J Glimcher
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

9.  Differential effects of phospholipids on skeletal alkaline phosphatase activity in extracts, in situ and in circulation.

Authors:  J R Farley; U M Jorch
Journal:  Arch Biochem Biophys       Date:  1983-03       Impact factor: 4.013

10.  Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae.

Authors:  E Canalis
Journal:  Metabolism       Date:  1983-01       Impact factor: 8.694

View more
  3 in total

1.  Low dose phenytoin is an osteogenic agent in the rat.

Authors:  T Ohta; J E Wergedal; H E Gruber; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

2.  Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats.

Authors:  T Ohta; J E Wergedal; T Matsuyama; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

3.  Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice.

Authors:  Kin-Hing William Lau; David J Baylink; Matilda H-C Sheng
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.